Effects of gap junctional blockers on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
The role of gap junctional communication in the coordination of vascular behavior has been well established experimentally. The aim of this study was to investigate whether the gap junctional blockers would inhibit cerebral vasospasm after experimental subarachnoid hemorrhage (SAH). We used the double-hemorrhage model of SAH with injection of autologous arterial blood into the cisterna magna on days 1 and 2. Octanol or carbenoxolone was administered intracisternally on day 3, and repeated on days 4 and 5. Angiography was performed before (day 0) and 7 days after (day 7) SAH, and the diameter of the basilar artery was measured. Paraffin blocks of brain tissues were prepared and sectioned for hematoxylin and eosin staining for morphologic analysis. Arterial narrowing in SAH + octanol group and SAH + carbenoxolone group at day 7 was significantly less than that in SAH-only group and each SAH + vehicle group, respectively. Less morphologic changes in SAH + octanol group and SAH + carbenoxolone group were observed when compared to that in SAH-only group and each SAH + vehicle group. Western blotting showed that carbenoxolone down-regulated Cx43 protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group. Gap junction blockers attenuate the experimental cerebral vasospasm and down-regulate the increase in expression of Cx43 protein after SAH in rabbits. These data suggest that gap junctions play an important role in the development of cerebral vasospasm.
Hong
Tao
T
Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, 17 Yong Wai Street, Nanchang 330006, China. hongtao2007126@126.com
Wang
Haitao
H
Wang
Yang
Y
Wang
Huan
H
D000818:Animals; D001488:Basilar Artery / Q000033:anatomy & histology* / Q000000981:diagnostic imaging / Q000378:metabolism; D002229:Carbenoxolone / Q000627:therapeutic use*; D018031:Connexin 43 / Q000378:metabolism; D004195:Disease Models, Animal; D015536:Down-Regulation / Q000187:drug effects; D054351:Electrical Synapses / Q000187:drug effects*; D008297:Male; D000442:Octanols / Q000627:therapeutic use*; D011817:Rabbits; D011859:Radiography; D011897:Random Allocation; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D020301:Vasospasm, Intracranial / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology
D018031:Connexin 43; D000442:Octanols; D002229:Carbenoxolone